319 related articles for article (PubMed ID: 27442440)
21. Risk factors for mortality among adults registered on the routine drug resistant tuberculosis reporting database in the Eastern Cape Province, South Africa, 2011 to 2013.
Chingonzoh R; Manesen MR; Madlavu MJ; Sopiseka N; Nokwe M; Emwerem M; Musekiwa A; Kuonza LR
PLoS One; 2018; 13(8):e0202469. PubMed ID: 30133504
[TBL] [Abstract][Full Text] [Related]
22. Adjusting the Effect of Integrating Antiretroviral Therapy and Tuberculosis Treatment on Mortality for Noncompliance: A Time-varying Instrumental Variables Analysis.
Yende-Zuma N; Mwambi H; Vansteelandt S
Epidemiology; 2019 Mar; 30(2):197-203. PubMed ID: 30720587
[TBL] [Abstract][Full Text] [Related]
23. Preferential adherence to antiretroviral therapy over tuberculosis treatment: a qualitative study of drug-resistant TB/HIV co-infected patients in South Africa.
Daftary A; Padayatchi N; O'Donnell M
Glob Public Health; 2014; 9(9):1107-16. PubMed ID: 25035943
[TBL] [Abstract][Full Text] [Related]
24. Do common mental disorders decline over time in TB/HIV co-infected and HIV patients without TB who are on antiretroviral treatment?
Deribew A; Deribe K; Reda AA; Tesfaye M; Hailmichael Y; Maja T
BMC Psychiatry; 2013 Jun; 13():174. PubMed ID: 23802647
[TBL] [Abstract][Full Text] [Related]
25. A comparative study of tuberculosis patients initiated on ART and receiving different models of TB-HIV care.
Schulz SA; Draper HR; Naidoo P
Int J Tuberc Lung Dis; 2013 Dec; 17(12):1558-63. PubMed ID: 24200268
[TBL] [Abstract][Full Text] [Related]
26. Adherence Measured Using Electronic Dose Monitoring is Associated with Emergent Antiretroviral Resistance and Poor Outcomes in People with Human Immunodeficiency Virus/AIDS and Multidrug-Resistant Tuberculosis.
Bateman M; Wolf A; Chimukangara B; Brust JCM; Lessells R; Amico R; Boodhram R; Singh N; Orrell C; Friedland G; Naidoo K; Padayatchi N; O'Donnell MR
Clin Infect Dis; 2022 Oct; 75(9):1489-1496. PubMed ID: 35352097
[TBL] [Abstract][Full Text] [Related]
27. The influence of integrated tuberculosis and human immunodeficiency virus service delivery on patient outcomes.
Uyei J; Coetzee D; Macinko J; Weinberg SL; Guttmacher S
Int J Tuberc Lung Dis; 2014 Mar; 18(3):315-21. PubMed ID: 24670569
[TBL] [Abstract][Full Text] [Related]
28. The Effect of Early Initiation of Antiretroviral Therapy in TB/HIV-Coinfected Patients: A Systematic Review and Meta-Analysis.
Abay SM; Deribe K; Reda AA; Biadgilign S; Datiko D; Assefa T; Todd M; Deribew A
J Int Assoc Provid AIDS Care; 2015; 14(6):560-70. PubMed ID: 26289343
[TBL] [Abstract][Full Text] [Related]
29. Unsuccessful TB treatment outcomes with a focus on HIV co-infected cases: a cross-sectional retrospective record review in a high-burdened province of South Africa.
Engelbrecht MC; Kigozi NG; Chikobvu P; Botha S; van Rensburg HCJ
BMC Health Serv Res; 2017 Jul; 17(1):470. PubMed ID: 28693508
[TBL] [Abstract][Full Text] [Related]
30. Integrating HIV care and treatment into tuberculosis clinics in Lusaka, Zambia: results from a before-after quasi-experimental study.
Herce ME; Morse J; Luhanga D; Harris J; Smith HJ; Besa S; Samungole G; Kancheya N; Muyoyeta M; Reid SE
BMC Infect Dis; 2018 Oct; 18(1):536. PubMed ID: 30367622
[TBL] [Abstract][Full Text] [Related]
31. DOT or SAT for Rifampicin-resistant tuberculosis? A non-randomized comparison in a high HIV-prevalence setting.
Mohr E; Daniels J; Beko B; Isaakidis P; Cox V; Steele SJ; Muller O; Snyman L; De Azevedo V; Shroufi A; Trivino Duran L; Hughes J
PLoS One; 2017; 12(5):e0178054. PubMed ID: 28542441
[TBL] [Abstract][Full Text] [Related]
32. Human immunodeficiency virus-associated tuberculosis care in Botswana: evidence from a real-world setting.
Muyaya LM; Musanda EM; Tamuzi JL
BMC Infect Dis; 2019 Sep; 19(1):767. PubMed ID: 31477055
[TBL] [Abstract][Full Text] [Related]
33. An integrated community TB-HIV adherence model provides an alternative to DOT for tuberculosis patients in Cape Town.
Kaplan R; Caldwell J; Hermans S; Adriaanse S; Mtwisha L; Bekker LG; Jennings K; Wood R
Int J Tuberc Lung Dis; 2016 Sep; 20(9):1185-91. PubMed ID: 27510244
[TBL] [Abstract][Full Text] [Related]
34. Nutrition support for HIV-TB co-infected adults in Senegal, West Africa: A randomized pilot implementation study.
Benzekri NA; Sambou JF; Tamba IT; Diatta JP; Sall I; Cisse O; Thiam M; Bassene G; Badji NM; Faye K; Sall F; Malomar JJ; Seydi M; Gottlieb GS
PLoS One; 2019; 14(7):e0219118. PubMed ID: 31318879
[TBL] [Abstract][Full Text] [Related]
35. Linking HIV-infected TB patients to cotrimoxazole prophylaxis and antiretroviral treatment in India.
Raizada N; Chauhan LS; Babu BS; Thakur R; Khera A; Wares DF; Sahu S; Bachani D; Rewari BB; Dewan PK
PLoS One; 2009 Jun; 4(6):e5999. PubMed ID: 19543396
[TBL] [Abstract][Full Text] [Related]
36. Safety and effectiveness of HAART in tuberculosis-HIV co-infected patients in Brazil.
dos Santos AP; Pacheco AG; Staviack A; Golub JE; Chaisson RE; Rolla VC; Kritski AL; Passos SR; de Queiroz Mello FC
Int J Tuberc Lung Dis; 2013 Feb; 17(2):192-7. PubMed ID: 23317954
[TBL] [Abstract][Full Text] [Related]
37. Treatment Adherence Among Persons Receiving Concurrent Multidrug-Resistant Tuberculosis and HIV Treatment in KwaZulu-Natal, South Africa.
Stephens F; Gandhi NR; Brust JCM; Mlisana K; Moodley P; Allana S; Campbell A; Shah S
J Acquir Immune Defic Syndr; 2019 Oct; 82(2):124-130. PubMed ID: 31513073
[TBL] [Abstract][Full Text] [Related]
38. Highly active antiretroviral therapy (HAART) in adults with tuberculosis: current status.
Kwara A; Flanigan TP; Carter EJ
Int J Tuberc Lung Dis; 2005 Mar; 9(3):248-57. PubMed ID: 15786886
[TBL] [Abstract][Full Text] [Related]
39. Successful TB treatment outcome and its associated factors among TB/HIV co-infected patients attending Gondar University Referral Hospital, Northwest Ethiopia: an institution based cross-sectional study.
Sinshaw Y; Alemu S; Fekadu A; Gizachew M
BMC Infect Dis; 2017 Feb; 17(1):132. PubMed ID: 28178936
[TBL] [Abstract][Full Text] [Related]
40. Comparison of treatment outcomes of new smear-positive pulmonary tuberculosis patients by HIV and antiretroviral status in a TB/HIV clinic, Malawi.
Tweya H; Feldacker C; Phiri S; Ben-Smith A; Fenner L; Jahn A; Kalulu M; Weigel R; Kamba C; Banda R; Egger M; Keiser O
PLoS One; 2013; 8(2):e56248. PubMed ID: 23457534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
